Kanser Nüks Korkusu ve Kişilik Özellikleri Arasındaki İlişki: Bir Sistematik Derleme Çalışması

Öz

Birçok kişilik özelliğinin kanser ile ilişkili çok sayıda sağlık sonuçlarıyla bağlantılı olduğu bulunmuştur. Kanser nüks korkusu kanserden sağ kalanlar arasında en sık yaşanan ve bireylere sıkıntı veren sorunlardan birisidir. Bu sistematik derleme çalışmasının amacı, var olan alanyazını inceleyerek kişilik özellikleri ve kanser nüks korkusu arasındaki ilişkiye dair genel bir bakış açısı sağlamayı amaçlamaktadır. PubMed, EBSCOhost, Scopus ve Web of Science veritabanları, önceden belirlenen anahtar kelimeler kullanılarak taranmıştır. Sonuç olarak, 9 araştırma, bu çalışmanın dahil etme kriterlerini karşılamıştır. Derlemeye dahil edilen çalışmalarda kişilik özelliklerini incelemek amacıyla Beş Faktör Kişilik Modeli, D tipi kişilik, tehdit duyarlılığı ve mükemmeliyetçilik kullanılmıştır. Araştırmaların bulguları kişilik özelliklerinin kanser nüks korkusu ile anlamlı şekilde ilişkili olduğunu göstermiştir. Yüksek seviyede nörotizm, D tipi kişilik, tehdit duyarlılığı ve mükemmeliyetçilik artmış kanser nüks korkusu ile ilişkili bulunurken, yüksek seviyede sorumluluk ise azalmış kanser nüks korkusu ile ilişkili bulunmuştur. Ayrıca çalışmalardan bazıları, işlevsel ve işlevsel olmayan başa çıkma stratejileri, belirsizliğe tahammülsüzlük ve üstbilişsel inançlar gibi çeşitli psikososyal değişkenlerin kişilik ile kanser nüks korkusu arasındaki ilişkide aracılık rollerinin olduğuna dair bulgular ortaya koymuştur. Genel olarak, derlemeye dahil edilen çalışmaların bulguları kişilik özelliklerinin kanser nüks korkusu ile ilişkili olduğunu göstermiştir.

Anahtar Kelimeler

• Kanser Nüks Korkusu
• Kişilik Özellikleri
• Beş Faktör Kişilik Modeli

The Association Between Fear of Cancer Recurrence and Personality Traits: A Systematic Review

Öz

Several personality characteristics have been linked to a broad range of cancer-related outcomes. Fear of cancer recurrence (FCR) is one of the most frequently experienced and distressing issues among cancer survivors. This systematic review aimed to examine the existing literature to provide an overview of the association between personality traits and FCR. PubMed, EBSCOhost, Scopus, and Web of Science were searched using predefined keywords. As a result, 9 studies met the inclusion criteria. The Big Five, type D personality, threat sensitivity, and perfectionism were used to examine personality in the included studies. Findings indicated that FCR was significantly associated with these personality constructs. Higher levels of neuroticism, type D personality, threat sensitivity and perfectionism were linked to increased FCR, whereas higher levels of conscientiousness were associated with decreased FCR. Some studies also provided evidence for the mediating roles of various psychosocial factors, including adaptive and maladaptive coping strategies, intolerance of uncertainty, and metacognitive beliefs on the association between personality and FCR. Overall, the findings of the included studies demonstrated that personality seems to be related to FCR.

Anahtar Kelimeler

• Fear of Cancer Recurrence
• Personality Traits
• Five-Factor Personality Model

Kaynakça

1. 1. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2024. https://gco.iarc.who.int/today. Accessed on 24.08.2025.
2. 2. Türk Toraks Derneği Torasik Onkoloji Çalışma Grubu. 1-7 Nisan Kanser Haftası: Farkındalık, Destek Ve Umut. https://toraks.org.tr/files/mf/site/2024/04/2024-1-7-nisan-kanser-haftasi-basin-bildirisi-ed2da543.pdf Accessed 20.04.2025
3. 3. Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013; 22(5): 978-86
4. 4. Simonelli LE, Siegel SD, Duffy NM. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psychooncology. 2017; 26(10): 1444-54.
5. 5. Bergerot CD, Philip EJ, Bergerot PG, Siddiq N, Tinianov S, Lustberg M. Fear of cancer recurrence or progression: what is it and what can we do about it? In: American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology Annual Meeting; 2022 Apr; 42:1-10.
6. 6. Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016; 24: 3265-8.
7. 7. Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WW, Lebel S, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology. 2022; 31(6): 879-892.
8. 8. Mutsaers B, Jones G, Rutkowski N, Tomei C, Séguin Leclair C, Petricone-Westwood D, et al. When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer. 2016; 24: 4207-4218.

9. 9. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari, S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7: 300-322.
10. 10. Thewes B, Bell ML, Butow P, Beith J, Boyle F, Friedlander M, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psychooncology. 2013; 22(12): 2797-2806.
11. 11. Luo X, Li W, Yang Y, Humphris G, Zeng L, Zhang Z, et al. High fear of cancer recurrence in Chinese newly diagnosed cancer patients. Front Psychol. 2020; 11: 1287.
12. 12. Tran TXM, Jung SY, Lee EG, Cho H, Kim NY, Shim S, et al. Fear of cancer recurrence and its negative impact on health-related quality of life in long-term breast cancer survivors. Cancer Res Treat. 2022; 54(4): 1065-1073
13. 13. Shin J, Shin DW, Lee J, Hwang J, Lee JE, Cho B, et al. Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study. BMC Cancer. 2022; 22(1): 414.
14. 14. Butow P, Sharpe L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park). 2018; 32(1): 32-8.
15. 15. Séguin Leclair C, Lebel S, Westmaas JL. The relationship between fear of cancer recurrence and health behaviors: A nationwide longitudinal study of cancer survivors. Health Psychol. 2019; 38(7): 596–605
16. 16. Williams JTW, Pearce A, Smith AB. A Systematic Review of Fear of Cancer Recurrence Related Healthcare Use and Intervention Cost-Effectiveness. Psychooncology. 2021; 30(8): 1185–1195.
17. 17. Champagne A, Ivers H, Savard J. Utilization of health care services in cancer patients with elevated fear of cancer recurrence. Psychooncology. 2018; 27(8): 1958-64
18. 18. Niu L, Liang Y, Niu M. Factors influencing fear of cancer recurrence in patients with breast cancer: evidence from a survey in Yancheng, China. J Obstet Gynaecol Res. 2019; 45(7): 1319-1327.
19. 19. Zhang X, Sun D, Qin N, Liu M, Jiang N, Li X. Factors correlated with fear of cancer recurrence in cancer survivors: a meta-analysis. Cancer Nurs. 2022;45(5): 406-415.
20. 20. Calderon C, Gustems M, Galán-Moral R, Muñoz-Sánchez MM, Ostios-García L, Jiménez-Fonseca P. Fear of recurrence in advanced cancer patients: sociodemographic, clinical, and psychological correlates. Cancers. 2024; 16(5): 909.
21. 21. Mell CA, Jewett PI, Teoh D, Vogel RI, Everson-Rose SA. Psychosocial predictors of fear of cancer recurrence in a cohort of gynecologic cancer survivors. Psychooncology. 2022; 31(12): 2141-8.
22. 22. Yang Y, Humphris G, Sun H, Li W, Hao Y, Liu T, et al. Psychometric properties of the Chinese version Fear of Cancer Recurrence Questionnaire-7 (FCR-7). Prof Psychol Res Pr. 2019; 50(6): 376-383.
23. 23. Luo X, Li W, Yang Y, Humphris G, Zeng L, Zhang Z, et al. High fear of cancer recurrence in Chinese newly diagnosed cancer patients. Front Psychol. 2020; 11; 1287.
24. 24. Skaali T, Fossa SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, et al. Fear of recurrence in long-term testicular cancer survivors. Psychoocology. 2009; 18(6): 580–588.
25. 25. Goodwin RD, Friedman HS. Health status and the five-factor personality traits in a nationally representative sample. J Health Psychol. 2006; 11(5): 643-654.
26. 26. Mavroeides G, Basta M, Vgontzas A, Karademas EC, Simos P, Koutra K. Prospective Associations Between Personality Traits and Major Depressive Disorder Symptom Severity: The Mediating Role of Illness Representations. Psychiat Quart. 2024; 95(3): 299-320.
27. 27. Dahl AA. Link Between Personality and Cancer. Future Oncol. 2010; 6(5): 691–707.
28. 28. Millar K, Purushotham AD, McLatchie E, George WD, Murray GD. A 1-year prospective study of individual variation in distress, and illness perceptions, after treatment for breast cancer. J Psychosom Res.2005; 58(4): 335-342.
29. 29. Mols F, Thong MS, van de Poll-Franse LV, Roukema JA, Denollet J. Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors. J Affect Disord.2012; 136(1-2): 26-34.
30. 30. Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
31. 31. Soriano EC, Perndorfer C, Siegel SD, Laurenceau JP. Threat sensitivity and fear of cancer recurrence: a daily diary study of reactivity and recovery as patients and spouses face the first mammogram post-diagnosis. J Psychosoc Oncol. 2019; 37(2): 131-144.
32. 32. Blom M, Guicherit OR, Hoogwegt MT. Perfectionism, intolerance of uncertainty and coping in relation to fear of cancer recurrence in breast cancer patients. Psychooncology. 2023; 32(4): 581-588.
33. 33. Ng DWL, Kwong A, Suen D, Chan M, Or A, Ng SS, et al. Fear of cancer recurrence among Chinese cancer survivors: prevalence and associations with metacognition and neuroticism. Psychooncology. 2019; 28(6): 1243-1251.
34. 34. Hosseini S, Salehi M, Jadidi M, Aghili M. The mediating role of cognitive emotion regulation explaining the casual relationship between personality traits and fear of cancer recurrence in breast cancer survivors. Iran J Breast Dis. 2023; 16(2): 4-21.
35. 35. Cessna Palas JM, Hyland KA, Nelson AM, Small BJ, Jim HS, Jacobsen PB. An examination of the relationship of patient modifiable and non-modifiable characteristics with fear of cancer recurrence among colorectal cancer survivors. Support Care Cancer. 2021; 29: 869-876.
36. 36. Homan E, Kwakkenbos L, Deuning-Smit E, Jansen F, Verdonck-de Leeuw IM, Takes RP, et al. (2024). Three-year trajectories and associated factors of fear of cancer recurrence in newly diagnosed head and neck cancer patients: a longitudinal study. J Cancer Surviv. 2024; 1-13.
37. 37. Nilsson R, Næss-Andresen TF, Myklebust TÅ, Bernklev T, Kersten H, Haug ES. Fear of recurrence in prostate cancer patients: a cross-sectional study after radical prostatectomy or active surveillance. Eur Urol Open Sci. 2021; 25: 44-51.
38. 38. Liao KYH, Yeung NC, Wong CC, Warmoth K, Lu Q. Fear of cancer recurrence and physical well-being among Chinese cancer survivors: the role of conscientiousness, positive reappraisal and hopelessness. Support Care Cancer. 2017; 25: 1141-1149.
39. 39. Alvisi MF, Dordoni P, Rancati T, Avuzzi B, Nicolai N, Badenchini F, et al. Supporting patients with untreated prostate cancer on active surveillance: what causes an increase in anxiety during the first 10 months?. Front Psychol. 2020; 11: 576459.
40. 40. Contrada RJ, Leventhal H, O'Leary A. Personality and health. Handbook of personality: Theory and research. 1990; 638-669.
41. 41. Strickhouser JE, Zell E, Krizan Z. Does personality predict health and well-being? A metasynthesis. Health Psychol. 2017; 36(8): 797-810.
42. 42. Smith TW, MacKenzie J. Personality and risk of physical illness. Annu Rev Clin Psychol. 2006; 2(1): 435-467.
43. 43. Grogan CS, Turiano NA, Habenicht A, McGeehan M, O'Súilleabháin PS. Personality traits and mediating pathways to mortality risk: A systematic review. Health Psychol. 2024; 43(3): 214.
44. 44. Wintraecken VM, Vulik S, de Wild S, Dirksen C, Koppert LB, de Vries J, et al. A descriptive systematic review of the relationship between personality traits and quality of life of women with non-metastatic breast cancer. BMC Cancer. 2022; 22(1): 426.
45. 45. Hajek A, Kretzler B, König HH. Personality and the use of cancer screenings: a systematic review. PLoS One. 2020; 15(12): e0244655.
46. 46. Ode S, Robinson MD, Wilkowski BM. Can one’s temper be cooled? A role for agreeableness in moderating neuroticism’s influence on anger and aggression. J Res Pers. 2008; 42(2): 295-311.
47. 47. Macía P, Gorbeña S, Gómez A, Barranco M, Iraurgi I. Role of neuroticism and extraversion in the emotional health of people with cancer. Heliyon. 2020; 6(7): 04281
48. 48. Shipley BA, Weiss A, Der G, Taylor MD, Deary IJ. Neuroticism, extraversion, and mortality in the UK Health and Lifestyle Survey: a 21-year prospective cohort study. Biopsychosoc Med. 2007; 69(9): 923-931.
49. 49. Barlow DH, Ellard KK, Sauer-Zavala S, Bullis JR, Carl JR. The origins of neuroticism. Perspect Psychol Sci. 2014; 9(5): 481-496.
50. 50. Robinson MD, Irvin RL, Asad MR, Fereidouni H. Neuroticism’s link to threat sensitivity: Evidence from a dynamic affect reactivity task. Emotion. 2025; 25(4): 884–895.
51. 51. Soto CJ, Jackson JJ. Five-factor model of personality. J Res Pers. 2013; 42: 1285-1302.
52. 52. Trudel-Fitzgerald C, Savard J, Slim LM, Roy RC, Flett GL, Hewitt PL, et al. The relationship of perfectionism with psychological symptoms in cancer patients and the contributing role of hyperarousability and coping. Psychol Health. 2017; 32(4): 381-401.
53. 53. Coutts‐Bain D, Sharpe L, Pradhan P, Russell H, Heathcote LC, Costa D. Are fear of cancer recurrence and fear of progression equivalent constructs?. Psychooncology. 2022; 31(8): 1381-1389.